Clinical Trials Sponsored by NoNO Inc.

Total 37563 results

Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan (LIGHT-NING)

Non-Small Cell Lung Cancer

Japan
Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread

Cancer of Head and Neck | Cancer of the Head | Cancer of the Neck

Japan
Astellas Pharma Inc
Ono Pharmaceutical Co. Ltd

Completed

ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

Osteoporosis | Bone Loss, Age-Related

Japan
Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Renal Cell Carcinoma

United States, Canada, Italy, Finland
Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

Phase I Biomarker Study (BMS-936558)

Renal Cell Carcinoma

United States, France, Spain
Ono Pharmaceutical Co. Ltd
Astellas Pharma Inc

Completed

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Involutional Osteoporosis

Japan
Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants

Kidney Cancer | Renal Cancer

Japan
Ono Pharmaceutical Co. Ltd
Astellas Pharma Inc

Completed

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Involutional Osteoporosis
Novo Nordisk A/S
Sponsor: Corvidia Therapeutics Inc, a subsidiary of Novo Nordisk A/S

Completed

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. (RESCUE-2)

Inflammation | Chronic Kidney Disease | Cardiovascular Risk

Japan
Aalborg University Hospital
Novo Nordisk A/S; DexCom, Inc.

Not yet recruiting

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy (DiaTRUST)

Type 2 Diabetes Treated With Insulin

Denmark
Tahitian Noni International, Inc.
University of Illinois at Chicago

Completed

Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Heavy Smokers

DNA Damage

United States
Forma Therapeutics, Inc.
Emory University

Recruiting

Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease

Sickle Cell Disease

United States
Hôpital NOVO

Not yet recruiting

Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders (IRTIPAP)

Post Traumatic Stress Disorder

France
Hôpital NOVO

Recruiting

Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area (MPSAT-ETP)

COPD

France
Hôpital NOVO

Recruiting

Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS (CopSCA)

Acute Myocardial Infarction

France
Hôpital NOVO

Completed

Assessment of a Procedure for Managing Oral Anticoagulants (NACO) in the Management of Fractures (STOP-NACO)

Femur Fracture

France
Hôpital NOVO

Active, not recruiting

Biological Monitoring by a Nurse for Heart Failure Patients. (IC-SPEC)

Heart Failure

France
Hôpital NOVO

Completed

Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients (POSIT-HEMI)

Hemiplegia and/or Hemiparesis Following Stroke

France
Hôpital NOVO

Completed

Intra-abdominal Umbilical Vein Aneurysm (AVO)

Obstetric Complication

France
Hôpital NOVO

Completed

The Future of Revascularization Using a Bioprotec Graft (REVATEC)

Peripheral Artery Disease

France
Taiwan Carbon Nano Technology Corporation
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Recruiting

Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge

Vaginitis | Vaginal Infection

Taiwan
Hôpital NOVO

Recruiting

Assessment of the Impact of the Return Home of Premature Newborns Less Than 2 Kilos Morbidity/Mortality (Petit-Poids)

Premature Birth

France
Hôpital NOVO

Recruiting

Recognition of a Cardiac Arrest Within the EMS (ACR90)

Cardiac Arrest

France
Hôpital NOVO

Recruiting

Effect of Tourniquet Abstention on Pain Reduction in Venous Sampling in the Elderly People (NO-GARROT)

Venous Puncture

France
Hôpital NOVO

Recruiting

Efficacy of Non-instrumental Pleural Chest Physiotherapy (KINEPANCH)

Infectious Pleural Effusion

France
Hôpital NOVO

Completed

Patients' Choice of Health Care Provider for Monitoring Their Pregnancy (Grossesse-Cx)

Pregnancy Related

France
Bristol-Myers Squibb
Medarex; Ono Pharma USA Inc

Completed

Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Malignant Melanoma

United States
Hôpital NOVO

Recruiting

Comparison of CT Scan Between Patients With Axial Spondyloarthritis and Control Subjects (SPA-THORAX)

Axial Spondyloarthritis

France
Hôpital NOVO

Recruiting

Total Post-thyroidectomy Hypocalcemia After Preoperative Cholecalciferol Supplementation (CAVITHY)

Hypocalcemia

France
Hôpital NOVO

Completed

Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19 (COPreDex)

Coronavirus Infection

France
Hôpital NOVO

Completed

Preterm Infants Born to Homeless Mothers. (PREMA-NEUF)

Prematurity; Extreme

France
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Adhera Health, Inc.
Novo Nordisk A/S; Hospital Miguel Servet

Completed

Digital Health Intervention for Caregivers Emotional and Self-management Support of Children With Type 1 Diabetes (CARING-T1D)

Diabetes Mellitus, Type 1

Spain
Eisai Co., Ltd.
Ono Pharmaceutical Co. Ltd

Active, not recruiting

A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor

Solid Neoplasms

Japan
Eisai Co., Ltd.
Ono Pharmaceutical Co. Ltd

Completed

A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd; Seagen Inc.

Terminated

A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, (CheckMate 812)

Hodgkin's Disease

United States, Japan, Puerto Rico
ProofPilot
Noho Health

Completed

Nourishing Hair, Skin & Nails Supplement Study (Derm Aid)

Skin Aging | Skin Laxity | Hair Loss | Cosmetic Acne | Nails; Soft

United States
Keystone Nano, Inc
Milton S. Hershey Medical Center; University of Virginia

Not yet recruiting

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (KNAN2001)

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory

United States
Keystone Nano, Inc
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Ceramide NanoLiposome in Patients With Advanced Solid Tumors

Carcinoma | Cancer | Solid Tumors | Tumor

United States
Novo Nordisk A/S

Not yet recruiting

A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity

Obesity | Overweight

United States
Novo Nordisk A/S

Recruiting

Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease

Alcohol-related Liver Disease

Czechia, Denmark, Italy, Netherlands, Canada, Spain, United States, Australia, Japan, Greece, France, Poland, Bulgaria, Germany
Novo Nordisk A/S

Recruiting

Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Recruiting

A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney Function

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Recruiting

A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People

Healthy Volunteers | Cardiometabolic Diseases

Netherlands
Novo Nordisk A/S

Recruiting

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise (REIMAGINE 1)

Type 2 Diabetes

United States, Serbia, Italy, China, Poland, Hungary, Saudi Arabia
Novo Nordisk A/S

Not yet recruiting

Special Use - Results Surveillance on Long-term Use With Wegovy®

Obesity

Japan
Novo Nordisk A/S

Recruiting

A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

Transthyretin Amyloid Cardiomyopathy (ATTR CM)

United States, Netherlands, Germany, Canada, Czechia, France, Italy, Portugal, Spain
Novo Nordisk A/S

Recruiting

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Type 2 Diabetes

United States, Taiwan, Australia, Hungary, Germany, India, Canada, Spain, Czechia, Argentina, Poland, Colombia, South Africa, France, Greece, Romania
Novo Nordisk A/S

Recruiting

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation (ATHENA)

Heart Failure | Systemic Inflammation

Spain, Malaysia, United States, Greece, Australia, France, Czechia, India, Canada, Turkey, Portugal, Poland, United Kingdom, Germany, Argentina, Bulgaria
Novo Nordisk A/S

Recruiting

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

Obesity | Type 2 Diabetes | Chronic Kidney Disease

United States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Slovakia, Hungary, Brazil

3

Subscribe